ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (458 K)

Article Toolbox
  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.fct.2008.03.007    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2008 Elsevier Ltd All rights reserved.

Modulatory effects of N-acetylcysteine on hyperoxaluric manifestations in rat kidney

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Rakesh K. Bijarniaa, Tanzeer Kaura, Kanika Aggarwalb, S.K. Singlab and Chanderdeep Tandona, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan 173 215, India

bDepartment of Biochemistry, Panjab University, Chandigarh, India


Received 17 August 2007; 
accepted 4 March 2008. 
Available online 10 March 2008.

Abstract

Hyperoxaluria is a condition where excessive oxalate is present in the urine. Many reports have documented free radical generation followed by hyperoxaluria as a consequence of which calcium oxalate deposition occurs in the kidney tissue. The present in vivo study was designed to investigate the potential of N-acetylcysteine in modulating hyperoxaluric manifestation induced by sodium oxalate in the rat kidneys. Male wistar rats in one group were administered single dose of sodium oxalate (70 mg/kg body weight) intraperitoneally to induce hyperoxaluric conditions and in the other group, rats were injected N-acetylcysteine (NAC) (200 mg/kg body weight) intraperitoneally, half an hour after sodium oxalate dose. The treatment is for a period of 24 h. N-acetylcysteine significantly reduced hyperoxaluria caused oxidative stress by reducing lipid peroxidation, restoring antioxidant enzymes activity in kidney tissue, followed by reduction in impairment of renal functioning. In addition, NAC administration reduced the number of calcium oxalate monohydrate (COM) crystals in the urine as observed under polarization microscope. Histological analysis depicted that NAC treatment decreased renal epithelial damage, inflammation and restored normal glomeruli morphology. Thus, it shows that use of an extraneous antioxidant may prove beneficial for combating the conditions of oxidative stress produced by hyperoxaluria.

Keywords: Creatinine; Hyperoxaluria; Lipid peroxidation; N-acetylcysteine; Oxidative stress; Urea

Abbreviations: NAC, N-acetylcysteine; COD, calcium oxalate dihydrate; COM, calcium oxalate monohydrate; MDA, malondialdehyde; HCl, hydrochloric acid; SOD, superoxide dismutase; CAT, catalase; w.r.t., with respect to; NF-κB, nuclear factor- κB

Article Outline

1. Introduction
2. Material and methods
2.1. Test material
2.2. Animals and treatments
2.3. Biochemical assays in urine and serum
2.4. Parameters for oxidative stress and antioxidant status in renal tissue
2.5. Urinary crystal study
2.6. Histopathological studies
2.7. Statistical analysis
3. Results
3.1. Evaluation of renal functioning
3.2. Renal oxidative stress
3.3. Renal antioxidant status
3.4. Urinary crystals
3.5. Histological analysis
4. Discussion
Conflict of interest statement
Acknowledgements
References



Corresponding Author Contact InformationCorresponding author. Tel.: +91 9816226719.

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.